Rawlins M D, Henderson D B, Hijab A R
Eur J Clin Pharmacol. 1977 Apr 20;11(4):283-6. doi: 10.1007/BF00607678.
Plasma paracetamol concentrations were measured in 6 volunteers after single intravenous (1000 mg) and oral (500 mg, 1000 mg and 2000 mg) doses of the drug. Paracetamol levels declined multiphasically with a mean clearance after intravenous administration of 352 +/- 40 ml/min. A two-compartment open model appeared to describe the decline adequately. Comparison of the areas under the plasma concentration-time curves (AUC) indicated that oral bioavailability increased from 0.63 +/- 0.02 after 500 mg, to 0.89 +/- 0.04 and 0.87 +/- 0.08 after 1000 mg and 2000 mg, respectively. As a consequence of the incomplete bioavailability of paracetamol, as well as its multicompartmental distribution, accurate estimates of its distribution volume and clearance cannot be obtained if the drug is given orally. However, an estimate of its total plasma clearance may be derived from the AUC after a 500 mg oral dose.
对6名志愿者单次静脉注射(1000毫克)和口服(500毫克、1000毫克和2000毫克)该药物后测定了血浆对乙酰氨基酚浓度。静脉注射后对乙酰氨基酚水平呈多相下降,静脉给药后的平均清除率为352±40毫升/分钟。二室开放模型似乎能充分描述其下降情况。血浆浓度-时间曲线下面积(AUC)的比较表明,口服生物利用度从500毫克后的0.63±0.02分别增至1000毫克和2000毫克后的0.89±0.04和0.87±0.08。由于对乙酰氨基酚生物利用度不完全及其多室分布,如果口服给药,无法获得其分布容积和清除率的准确估计值。然而,500毫克口服剂量后的AUC可得出其总血浆清除率的估计值。